血液系统恶性肿瘤和良性血液系统疾病的分子方面。
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders.
机构信息
Department of Pathophysiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Clinic of Hematology, Filantropia City Hospital, 200143 Craiova, Romania.
出版信息
Int J Mol Sci. 2023 Jun 6;24(12):9816. doi: 10.3390/ijms24129816.
Abstract
Hematology represents a dynamic specialty in clinical medicine that requires solid knowledge of normal and pathological hematopoiesis, cytomorphology, pathology, immunology, genetics and molecular biology [...].
摘要
血液学是临床医学中一个充满活力的专业，需要对正常和病理造血、细胞形态学、病理学、免疫学、遗传学和分子生物学有扎实的知识 [... ]。
相似文献
1
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders.血液系统恶性肿瘤和良性血液系统疾病的分子方面。
Int J Mol Sci. 2023 Jun 6;24(12):9816. doi: 10.3390/ijms24129816.
2
3
RNA-binding proteins in hematopoiesis and hematological malignancy.RNA 结合蛋白在造血和血液系统恶性肿瘤中的作用。
Blood. 2019 May 30;133(22):2365-2373. doi: 10.1182/blood-2018-10-839985. Epub 2019 Apr 9.
4
The role of homeobox genes in normal hematopoiesis and hematological malignancies.同源框基因在正常造血及血液系统恶性肿瘤中的作用。
Leukemia. 1999 Nov;13(11):1675-90. doi: 10.1038/sj.leu.2401562.
5
Epigenetics of hematopoiesis and hematological malignancies.造血作用与血液系统恶性肿瘤的表观遗传学
Genes Dev. 2016 Sep 15;30(18):2021-2041. doi: 10.1101/gad.284109.116.
6
Guest editorial: Epigenetics of hematopoiesis and hematological malignancies.特邀社论：造血作用与血液系统恶性肿瘤的表观遗传学
Int J Hematol. 2012 Oct;96(4):403-4. doi: 10.1007/s12185-012-1184-9. Epub 2012 Sep 27.
7
MicroRNAs in hematological malignancies.血液恶性肿瘤中的 microRNAs。
Blood Rev. 2013 May;27(3):143-54. doi: 10.1016/j.blre.2013.04.002. Epub 2013 Apr 25.
8
The role of miR-29 family members in malignant hematopoiesis.微小RNA-29家族成员在恶性造血中的作用。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Dec;158(4):489-501. doi: 10.5507/bp.2014.029. Epub 2014 Jun 23.
9
Emerging roles for tRNAs in hematopoiesis and hematological malignancies.tRNA 在造血和血液系统恶性肿瘤中的新兴作用。
Trends Immunol. 2022 Jun;43(6):466-477. doi: 10.1016/j.it.2022.03.009. Epub 2022 Apr 27.
10
Biological implications of clonal hematopoiesis.克隆性造血的生物学意义。
Exp Hematol. 2019 Sep;77:1-5. doi: 10.1016/j.exphem.2019.08.004. Epub 2019 Aug 28.
引用本文的文献
1
A new perspective on hematological malignancies: m6A modification in immune microenvironment.血液系统恶性肿瘤的新视角：免疫微环境中的m6A修饰
Front Immunol. 2024 May 28;15:1374390. doi: 10.3389/fimmu.2024.1374390. eCollection 2024.
本文引用的文献
1
Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities.异基因干细胞移植治疗急性髓系白血病：障碍与机遇概述
World J Clin Cases. 2023 Jan 16;11(2):268-291. doi: 10.12998/wjcc.v11.i2.268.
2
The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting.急性髓系白血病干细胞在微环境中的起源与演变：从生物学特性到治疗靶点
Cell Death Discov. 2022 Sep 26;8(1):397. doi: 10.1038/s41420-022-01193-0.
3
Concomitant Inhibition of IRE1α/XBP1 Axis of UPR and PARP: A Promising Therapeutic Approach against c-Myc and Gammaherpesvirus-Driven B-Cell Lymphomas.同时抑制 UPR 的 IRE1α/XBP1 轴和 PARP：一种针对 c-Myc 和γ疱疹病毒驱动的 B 细胞淋巴瘤的有前途的治疗方法。
Int J Mol Sci. 2022 Aug 14;23(16):9113. doi: 10.3390/ijms23169113.
4
High-Throughput CRISPR Screening in Hematological Neoplasms.血液肿瘤中的高通量CRISPR筛选
Cancers (Basel). 2022 Jul 25;14(15):3612. doi: 10.3390/cancers14153612.
5
Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line.核仁素在核仁磷酸蛋白突变的 OCI-AML 3 细胞系中的作用的蛋白质组学研究。
Int J Mol Sci. 2022 Jul 11;23(14):7655. doi: 10.3390/ijms23147655.
6
Hematopoietic Stem and Progenitor Cells (HSPCs) and Hematopoietic Microenvironment: Molecular and Bioinformatic Studies of the Zebrafish Models.造血干细胞和祖细胞 (HSPCs) 及造血微环境：斑马鱼模型的分子和生物信息学研究。
Int J Mol Sci. 2022 Jun 30;23(13):7285. doi: 10.3390/ijms23137285.
7
Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.原发性纵隔 B 细胞淋巴瘤中人类蛋白酪氨酸磷酸酶 PTP1B 反复出现的体细胞突变的生化、酶学和计算特征。
Int J Mol Sci. 2022 Jun 24;23(13):7060. doi: 10.3390/ijms23137060.
8
Mechanisms of Sensitivity and Resistance of Primary Effusion Lymphoma to Dimethyl Fumarate (DMF).原发性渗出性淋巴瘤对富马酸二甲酯（DMF）敏感性和耐药性的机制。
Int J Mol Sci. 2022 Jun 17;23(12):6773. doi: 10.3390/ijms23126773.
9
Antiphospholipid Antibodies and Lipids in Hematological Malignancies.抗磷脂抗体与血液系统恶性肿瘤中的脂质
Int J Mol Sci. 2022 Apr 8;23(8):4151. doi: 10.3390/ijms23084151.
10
Personalized Risk Schemes and Machine Learning to Empower Genomic Prognostication Models in Myelodysplastic Syndromes.个性化风险方案和机器学习赋能骨髓增生异常综合征的基因组预后模型。
Int J Mol Sci. 2022 Mar 3;23(5):2802. doi: 10.3390/ijms23052802.
Zotero 插件